Ventas, Inc. $VTR Shares Sold by Patton Fund Management Inc.

Patton Fund Management Inc. cut its stake in shares of Ventas, Inc. (NYSE:VTR) by 91.0% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 3,742 shares of the real estate investment trust’s stock after selling 37,962 shares during the quarter. Patton Fund Management Inc.’s holdings in Ventas were worth $262,000 at the end of the most recent quarter.

A number of other large investors have also made changes to their positions in the stock. Norges Bank purchased a new stake in Ventas during the second quarter worth about $344,740,000. Vanguard Group Inc. boosted its stake in shares of Ventas by 4.1% during the 2nd quarter. Vanguard Group Inc. now owns 71,796,312 shares of the real estate investment trust’s stock worth $4,533,937,000 after acquiring an additional 2,854,751 shares in the last quarter. Citigroup Inc. boosted its stake in shares of Ventas by 451.9% during the 2nd quarter. Citigroup Inc. now owns 2,316,344 shares of the real estate investment trust’s stock worth $146,277,000 after acquiring an additional 1,896,627 shares in the last quarter. State Street Corp grew its holdings in shares of Ventas by 5.2% in the 2nd quarter. State Street Corp now owns 27,998,629 shares of the real estate investment trust’s stock worth $1,781,267,000 after acquiring an additional 1,388,678 shares during the period. Finally, Invesco Ltd. increased its stake in Ventas by 36.1% in the 2nd quarter. Invesco Ltd. now owns 4,812,970 shares of the real estate investment trust’s stock valued at $303,939,000 after purchasing an additional 1,275,446 shares in the last quarter. Hedge funds and other institutional investors own 94.18% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on the company. Citigroup raised their price target on Ventas from $80.00 to $88.00 and gave the company a “buy” rating in a research report on Tuesday, November 11th. Cantor Fitzgerald raised their target price on shares of Ventas from $77.00 to $85.00 and gave the company an “overweight” rating in a report on Friday, October 31st. Evercore ISI lifted their target price on shares of Ventas from $77.00 to $80.00 and gave the stock an “outperform” rating in a research report on Monday, September 15th. Jefferies Financial Group reiterated a “buy” rating and issued a $93.00 price target on shares of Ventas in a research report on Monday, December 15th. Finally, UBS Group assumed coverage on shares of Ventas in a research note on Friday, September 19th. They set a “neutral” rating and a $73.00 price objective for the company. One research analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat.com, Ventas presently has an average rating of “Moderate Buy” and a consensus target price of $79.31.

Insiders Place Their Bets

In other Ventas news, CFO Robert F. Probst sold 33,591 shares of Ventas stock in a transaction on Wednesday, November 12th. The shares were sold at an average price of $76.77, for a total value of $2,578,781.07. Following the transaction, the chief financial officer owned 168,364 shares in the company, valued at $12,925,304.28. This trade represents a 16.63% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Debra A. Cafaro sold 317,258 shares of the company’s stock in a transaction on Thursday, October 30th. The stock was sold at an average price of $74.24, for a total value of $23,553,233.92. Following the sale, the chief executive officer owned 1,145,695 shares of the company’s stock, valued at approximately $85,056,396.80. The trade was a 21.69% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 688,184 shares of company stock valued at $50,726,248 over the last quarter. Company insiders own 1.00% of the company’s stock.

Ventas Price Performance

Ventas stock opened at $79.13 on Tuesday. The stock has a market capitalization of $37.17 billion, a P/E ratio of 152.18, a P/E/G ratio of 1.99 and a beta of 0.78. Ventas, Inc. has a 12-month low of $56.68 and a 12-month high of $81.89. The company has a debt-to-equity ratio of 1.01, a current ratio of 0.32 and a quick ratio of 0.32. The firm’s 50-day moving average is $76.30 and its two-hundred day moving average is $70.00.

Ventas (NYSE:VTR) last announced its quarterly earnings data on Wednesday, October 29th. The real estate investment trust reported $0.88 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.87 by $0.01. Ventas had a net margin of 4.28% and a return on equity of 2.05%. The business had revenue of $1.49 billion for the quarter, compared to the consensus estimate of $1.44 billion. During the same quarter in the prior year, the firm posted $0.80 earnings per share. The company’s quarterly revenue was up 20.5% compared to the same quarter last year. Ventas has set its FY 2025 guidance at 3.450-3.480 EPS. Equities analysts predict that Ventas, Inc. will post 3.4 earnings per share for the current year.

Ventas Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Wednesday, December 31st will be given a dividend of $0.48 per share. The ex-dividend date of this dividend is Wednesday, December 31st. This represents a $1.92 annualized dividend and a yield of 2.4%. Ventas’s dividend payout ratio is 369.23%.

About Ventas

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.